73. A patient refilling a prescription for atorvastatin complains about having a lot of muscle pain recently. What is the most appropriate action for the pharmacy technician?
Answer: A
Alerting the pharmacist to a possible adverse drug event is the most appropriate action.
In this scenario, the patient's complaint of significant muscle pain while taking atorvastatin raises concerns about a potential adverse drug reaction, such as myopathy or rhabdomyolysis, which are known side effects of statin medications.
A) alert the pharmacist to a possible adverse drug event.
This option is correct because muscle pain can indicate a serious adverse effect associated with atorvastatin. The pharmacy technician should promptly notify the pharmacist, who can then assess the patient's situation and determine if further medical evaluation or alternative treatment is warranted to ensure patient safety.
B) have the pharmacist recommend an OTC pain medication.
While recommending an OTC pain medication might provide temporary relief for the patient, it does not address the underlying issue of potential muscle damage caused by atorvastatin. This option fails to prioritize patient safety and the necessary evaluation of the drug's effects on the patient.
C) reassure the patient that this is a common side effect of statin therapy.
Although muscle pain can occur with statin therapy, reassuring the patient without further evaluation could be misleading and potentially harmful. This response does not adequately address the severity of the patient's symptoms or the risk of serious side effects, making it an inappropriate action.
D) substitute simvastatin in place of atorvastatin.
Substituting simvastatin for atorvastatin without proper assessment could overlook the possibility of the patient experiencing similar side effects with another statin. This option is premature and does not consider the need for a thorough evaluation of the patient's muscle pain and its potential causes.
Conclusion
In summary, alerting the pharmacist to the patient's report of muscle pain is crucial for ensuring patient safety and addressing potential adverse effects of atorvastatin. All other options fail to adequately assess or manage the patient's symptoms, highlighting the importance of proper communication and evaluation in pharmacy practice.